3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Brain Neoplasms
8
Seizures
6
Leukemia, Myeloid, Acute
3
Glioma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Glioblastoma
2
Central Nervous System Neoplasms
2
beta-Thalassemia
1
Postoperative Seizures After Brain Tumor Surgery
1
Pinealoma
1
Oligodendroglioma
1
Neurofibromatosis 1
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasm, Residual
1
Necrosis
1
Myelodysplastic Syndromes
1
Meningioma
1
Medulloblastoma
1
Leukemia, Myelomonocytic, Juvenile
1
Influenza, Human
1
Hematologic Neoplasms
1
Gliosarcoma
1
Epilepsy
1
Ependymoma
1
Chromosome Aberrations
1
Chromosome 7, monosomy
1
Astrocytoma
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Levetiracetam
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Postoperative Seizures After Brain Tumor Surgery
×
Levetiracetam
×
Clear all
NCT07239115
2026-05-28
PREVENT
Beijing Tiantan Hospital
Phase 3
Recruiting
558 enrolled